secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001104659-24-011616
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharma Director Anand Reddi resigns from board effective Feb 7, 2024
---------------------------------------------------------------------------

- Anand Reddi resigned from Board of Directors on Feb 7, 2024.
- He served as Chairman of Compensation Committee and member of Governance/Nominations Committee.
- No successor appointed or reason for resignation disclosed.
- Company did not provide any further details or comments on the departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465924011616/0001104659-24-011616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465924011616/tm245471d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-011616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer